Market Place
Sourcing Support
WuXi Biologics Germany Expands with Prefilled Syringe Line
13 Nov 2024 //
PR NEWSWIRE
WuXi Biologics Earns AAA MSCI ESG Rating For Second Year
07 Nov 2024 //
PRESS RELEASE
WuXi Biologics Launches WuXia™ RidGS for Cell Line Development
28 Oct 2024 //
PR NEWSWIRE
WuXi Biologics Wins ESG Platinum Award Fourth Year In Row
16 Oct 2024 //
PRESS RELEASE
China`s WuXi Explores Sale Of Pharma Operations As US Restrictions
03 Oct 2024 //
REUTERS
WuXi Biologics Included in Hang Seng ESG 50 Index
23 Sep 2024 //
PR NEWSWIRE
WuXi Completes First Scale-Up Of 2,000L WuXiUITM Bioprocess
30 Aug 2024 //
PRESS RELEASE
WuXi Biologics Reports Solid 2024 Interim Results
21 Aug 2024 //
PRESS RELEASE
Medigene And WuXi Biologics Enter Research Collaboration
08 Aug 2024 //
GLOBENEWSWIRE
WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US
08 Aug 2024 //
ENDPTS
WuXi Biologics In S&P Sustainability Yearbook 2024 (China)
06 Aug 2024 //
PRESS RELEASE
WuXi Biologics Facilities Recertified By EMA
01 Aug 2024 //
PR NEWSWIRE
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year
10 Jul 2024 //
PR NEWSWIRE
WuXi shares jump after BIOSECURE`s exclusion from defense bill
12 Jun 2024 //
FIERCE PHARMA
AGC Biologics, BioConnection forge partnership to be an alternative to WuXi
22 May 2024 //
ENDPTS
U.S. Biosecure Act Advances with Revised Timeline
14 May 2024 //
CONTRACT PHARMA
New bill sets decoupling deadline for industry`s work with WuXi
10 May 2024 //
FIERCE PHARMA
WuXi Bio pulls out of 2024 BIO convention
01 May 2024 //
FIERCE PHARMA
WuXi Biologics 2023 ESG Report Shows Sustainability Commitment
29 Apr 2024 //
PR NEWSWIRE
Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi
24 Apr 2024 //
ENDPTS
WuXi Biologics Reports Solid 2023 Annual Results
26 Mar 2024 //
PR NEWSWIRE
Hunting for ‘certainty and stability,’ WuXi Bio spotlights client relationships
26 Mar 2024 //
ENDPTS
Biotech trade association to split with China`s WuXi AppTec
14 Mar 2024 //
REUTERS
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
05 Mar 2024 //
PR NEWSWIRE
WuXi Biologics Ireland Site Receives Three ISO Certifications
01 Mar 2024 //
PRESS RELEASE
WuXi Biologics Recognized As ESG Top-Rated By Morningstar Sustainalytics
20 Feb 2024 //
PRESS RELEASE
Lawmakers’ explosive charges turn a global spotlight on China’s WuXi
14 Feb 2024 //
ENDPTS
WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over biotech bill
02 Feb 2024 //
REUTERS
WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland
31 Jan 2024 //
PR NEWSWIRE
WuXi Biologics Launches WuXiaADCC PLUSâ„¢ For Enhanced Antibodies
25 Jan 2024 //
PRESS RELEASE
WuXi Biologics Launches WuXia ADCC PLUS™
24 Jan 2024 //
PR NEWSWIRE
WuXi Biologics Granted US Patent For WuXiBodyâ„¢ Bispecific Platform
17 Jan 2024 //
PRESS RELEASE
WuXi Biologics CEO Presents At J.P. Morgan Healthcare Conference
12 Jan 2024 //
PRESS RELEASE
WuXi Biologics Signs Research Agreement With BioNTech For Antibodies
11 Jan 2024 //
PRESS RELEASE
WuXi Bio expands US presence; FujiFilm boosts autoinjector services
11 Jan 2024 //
ENDPTS
BioNTech pays WuXi $20M for 2 preclinical monoclonal antibodies
11 Jan 2024 //
FIERCE BIOTECH
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
09 Jan 2024 //
PRESS RELEASE
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts
08 Jan 2024 //
PRESS RELEASE
WuXi Biologics, WuXi AppTec plot expansions in US, China
08 Jan 2024 //
FIERCE PHARMA
WuXi Vaccines Wins Second Consecutive "Best Vaccine CMO Award" at AVEA 2023
12 Dec 2023 //
PR NEWSWIRE
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
06 Dec 2023 //
PR NEWSWIRE
WuXi Bio struggles amid CDMO industry downturn, stock plummets
04 Dec 2023 //
FIERCE PHARMA
WuXi ImplementedProcess with a Breakthrough Productivity of ~6 g/L/day
21 Nov 2023 //
PR NEWSWIRE
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
17 Nov 2023 //
PR NEWSWIRE
WuXi Biologics Receives AAA MSCI ESG Rating
07 Nov 2023 //
PR NEWSWIRE
WuXi XDC to funnel IPO proceeds into manufacturing expansions
07 Nov 2023 //
FIERCE PHARMA
WuXi TIDES boosts oligo, peptide offerings
26 Oct 2023 //
ENDPTS
WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug
17 Oct 2023 //
PR NEWSWIRE
IMIDomics Announces Strategic Agreement with WuXi Biologics
04 Oct 2023 //
BUSINESSWIRE
BioNTech reiterates presence in Africa; WuXi eyes first Chinese vaccine plant
28 Sep 2023 //
ENDPTS
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
26 Sep 2023 //
PR NEWSWIRE
WuXi plots hundreds of hires at first standalone vaccine plant
26 Sep 2023 //
FIERCE PHARMA
WuXi XDC Launches New Commercial Manufacturing Facilities
20 Sep 2023 //
PR NEWSWIRE
Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration
08 Sep 2023 //
PR NEWSWIRE
WuXi Biologics Reports Solid 2023 Interim Results
23 Aug 2023 //
PR NEWSWIRE
Acasti Announces WuXi Clinical as CRO to Conduct Phase 3 Trial for GTX-104
10 Jul 2023 //
PR NEWSWIRE
WuXi plans to spin off its bioconjugation subsidiary WuXi XDC
10 Jul 2023 //
FIERCE PHARMA
Pharmadule Morimatsu, WuXi Biologics Form Global Strategic Partnership
27 Jun 2023 //
CONTRACT PHARMA
WuXi Commits to Science Based Targets Initiative in its Net-Zero Journey
19 Jun 2023 //
PRESS RELEASE
WuXi Biologics to expand manufacturing operations in Germany
02 Jun 2023 //
FIERCE PHARMA
